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ense (http://creativecommons.org/Assessment of left ventricular function in patients with
ischemic cardiomyopathy has been mainly based on the
assessment of left ventricle ejection fraction (LVEF).1
However, over the past few decades, it has become
apparent that LVEF cannot reliably determine the prognosis
or even the course and clinical diagnosis of ischemic car-
diomyopathy in many cases.2,3 Moreover, intra and inter
ventricular mechanical dyssynchrony may further deterio-
rate left ventricle performance and clinical status. At this
point, cardiac resynchronization therapy (CRT) has been
proposed to improve patients’ quality of life and prog-
nosis.4 Nevertheless, questions remain regarding cardiac
CRT, including a) who may benefit from such an approach,
b) where is and how can we determine the best site for left
ventricle pacing, c) how can we measure response to CRT
and d) what methods can optimize response to CRT?
Over the years, ultrasound systems and advanced soft-
ware have allowed for the introduction of improved and
reliable techniques for the assessment of left ventricle
function. Evolving from m-mode assessment of limitedy of Hellenic Cardiological
.08.001
cal Society. Publishing services by
licenses/by-nc-nd/4.0/).parts of left ventricle motion to real time 2-dimensional
images and, more recently, using real time 3-dimension
images, which can be reliable and semi-automatically es-
timate stroke volume and ejection fraction.5e7 Further-
more, myocardial performance can now be assessed by
additional modalities such as tissue Doppler imaging (TDI)
and speckle recognition, which can be used to measure
myocardial deformation strain and strain rate to provide
additional information on myocardial performance, which
cannot be assessed by simply measuring changes in cavity
volumes.8e11 In addition, these modalities have less inter-
and intra-observer variability, which may be advantageous
in the recognition of patients with mechanical dyssyn-
chrony and the serial assessment of response to treatment
(see Figure 1).
Similar development was also observed in the assess-
ment of left ventricle dyssynchrony.12 M-mode can assess
the delay between anteroseptal and posterior walls but
with limited clinical value.13 Tissue Doppler imaging allows
for the identification of delays in multiple segments of the
left ventricle as summarized in the dyssynchrony index,
with the major limitation of angle dependency.14 Currently,
speckle tracking echocardiography and 3-dimensional im-
aging could provide a full data set from the entire ventricle.
It may be used to provide time-volume curves for each of
the 16 or 17 segments of the left ventricle, from which we
can easily estimate the time-to-peak segmental contraction
from each segment, allowing reproducible identification of
the sequential conduction in each patient.15 Despite the
ability of recent echocardiographic modalities to assess
even insignificant dyssynchrony, a series of large random-
ized studies failed to confirm the superiority of echocardi-
ography over the robust electrocardiographic assessment in
predicting response to CRT.16,17 However, the role of
echocardiography in the optimization of CRT continues toElsevier B.V. This is an open access article under the CC BY-NC-ND
Figure 1 Principles of speckle tracking echocardiography
Editorial 179be valuable; studies have shown that left ventricle lead
placement in the site of the latest activation may improve
response or even outcome of heart failure patients espe-
cially when this site is not in scar tissue in patients with
ischemic cardiomyopathy.18,19
Toumanidis et al. examines this exact issue in an
experimental model of ischemic heart failure in the terri-
tory supply by the left anterior descending artery.20 They
confirmed that the natural conduction system is the best
way to improve cardiac performance and left ventricle
pacing at the apex outside the ischemic area may produce
better results.
Currently, the optimum site of left ventricle pacing
cannot be determined based on simple tests but must
incorporate echocardiographic measurements, clinical
data, anatomy and the physiologic knowledge of the natu-
ral conduction system.
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